Skip to content

Self-Injury Treatment and Recovery in Veterans

A Brief Intervention to Reduce Nonsuicidal Self-Injury and Improve Functioning in Veterans

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05969080
Acronym
STRIVe
Enrollment
40
Registered
2023-08-01
Start date
2024-10-15
Completion date
2027-03-31
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self-Injurious Behavior

Keywords

Self-Injurious Behavior, Veterans

Brief summary

Nonsuicidal self-injury (NSSI) refers to the intentional destruction of one's own body tissue without suicidal intent and for purposes that are not socially sanctioned. While NSSI has been understudied among Veterans, the lifetime prevalence rate of NSSI in Veterans is approximately three times higher than the general population. Moreover, NSSI is associated with increased risk for violence, psychiatric distress, and marked impairment in psychosocial functioning. Even though NSSI is distinct from suicidal behaviors in several important ways, NSSI remains a strong predictor of a future suicide attempt. The primary goal of this project is to evaluate the treatment and acceptability of a brief intervention for NSSI that aims to reduce psychosocial impairment and NSSI behaviors in Veterans.

Detailed description

Nonsuicidal self-injury (NSSI) refers to the intentional destruction of one's own body tissue without suicidal intent and for purposes that are not socially sanctioned. While NSSI has been understudied among Veterans, the lifetime prevalence rate of NSSI in Veterans is approximately three times higher than the general population. Moreover, NSSI is associated with increased risk for violence, psychiatric distress, and marked impairment in psychosocial functioning. Even though NSSI is distinct from suicidal behaviors in several important ways, NSSI remains a strong predictor of a future suicide attempt. The primary goal of this project is to evaluate the treatment and acceptability of a brief intervention for NSSI that aims to reduce psychosocial impairment and NSSI behaviors in Veterans. This treatment, known as the Treatment for Self-Injurious Behaviors (T-SIB) incorporates evidence-based approaches to replace NSSI with behaviors that improve psychoso ial functioning. A core component of T-SIB is functional assessment that identifies the antecedents and consequences of NSSI. This project will enhance T-SIB by using ecological momentary assessment (EMA) to conduct NSSI functional assessment in-vivo. EMA reduces retrospective recall bias and can increase engagement with therapeutic goals.

Interventions

BEHAVIORALTreatment for Self-Injurious Behaviors

Treatment for Self-Injurious Behaviors (T-SIB) incorporates evidence-based approaches to replace NSSI with behaviors that improve psychosocial functioning.

OTHERTreatment As Usual

Participants randomized to the TAU condition will be provided with referrals to both Durham VA and local community mental health resources and offered a consult for Durham VA mental health services.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Past service in the United States military * Nonsuicidal self-injury engagement on 2 occasions in past 30 days * Fluent in English * Able to provide voluntary informed consent

Exclusion criteria

* Lifetime history of psychosis, mania, or hypomania * Imminent risk for suicide/homicide warranting immediate intervention * Unable/unwilling to complete study procedures

Design outcomes

Primary

MeasureTime frameDescription
Feasibility as measured by number of participants enrolled2 years after study enrollment beginsAll participants (N = 40) will need to be enrolled by the end of the second year of the study to consider the recruitment benchmark met.
Feasibility as measured rate of retentionEnd of treatment, about nine weeks after beginning the studyRetention will be measured by the number of participants who complete at least six T-SIB treatment sessions. This benchmark will be considered meet if at least 2/3 of the 20 participants randomized to T-SIB complete at least 6 treatment sessions.

Secondary

MeasureTime frameDescription
Number of participants who report satisfaction with the T-SIB treatmentEnd of treatment, about nine weeks after beginning the studyParticipant satisfaction will be measured with the Client Satisfaction Questionnaire (CSQ-8). Total scores on the CSQ-8 range from 8 to 32, which higher scores indicating higher satisfaction. A cut score of 24 will be used such that if the CSQ-8 score exceeds 24, that patient is deemed to have been satisfied with the treatment.

Countries

United States

Contacts

CONTACTTate F Halverson, PhD
Tate.Halverson@va.gov(919) 286-0411
CONTACTAngela C Kirby, MS
angela.kirby@va.gov(919) 286-0411
PRINCIPAL_INVESTIGATORTate F Halverson, PhD

Durham VA Medical Center, Durham, NC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026